Literature DB >> 16120411

Exercise testing as a diagnostic entity in mitochondrial myopathies.

Mark Tarnopolsky1.   

Abstract

Exercise intolerance is one of the most common symptoms in patients with mitochondrial myopathies (MM). At the whole body level, this is characterized by a reduction in maximal oxygen consumption (VO2max) with an excessive carbon dioxide production (VCO2), increased rating of perceived exertion and a hyperdynamic circulatory response at a given exercise intensity. Fewer patients with MM display overt muscle atrophy and weakness even in the absence of a peripheral neuropathy. At the level of the skeletal muscle, the abnormal exercise response in MM patients is characterized by an increase in; delivery of oxygen relative to extraction (reduced myoglobin or hemoglobin desaturation), lactate production, phosphocreatine hydrolysis and time of post-exercise PCr and ADP recovery. Classically, the characterization of exercise intolerance is performed using cycle ergometry with measurements of VO2, VCO2, respiratory exchange ratio (RER = VCO2/VO2), heart rate, minute ventilation, rating of perceived exertion, and cardiac output (where available). Exercise protocols to maximum or for a given time period at a set workload can differentiate MM from controls with a sensitivity of 0.63-0.75 and a specificity of 0.70-0.90. Modified hand-grip exercise protocols, especially if coupled with simultaneous measurements of myoglobin/hemoglobin desaturation (near infra-red spectroscopy) or venous oxygenation, can achieve similar or higher levels of sensitivity and specificity. Similarly, exercise coupled with muscle phosphocreatine/Pi ratios, PCr, pH or ADP recovery kinetics, determined using magnetic resonance spectroscopy are useful in differentiating MM, but are limited by availability, experience and cost. In summary, aerobic exercise testing with some measurement of oxygen consumption can be performed in most institutions and can provide valuable information in the both the work-up of patients with suspected MM as well as in the monitoring of therapy in such patients.

Entities:  

Year:  2004        PMID: 16120411     DOI: 10.1016/j.mito.2004.07.011

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  12 in total

1.  Unexplained exertional intolerance associated with impaired systemic oxygen extraction.

Authors:  Kathryn H Melamed; Mário Santos; Rudolf K F Oliveira; Mariana Faria Urbina; Donna Felsenstein; Alexander R Opotowsky; Aaron B Waxman; David M Systrom
Journal:  Eur J Appl Physiol       Date:  2019-09-06       Impact factor: 3.078

2.  Skeletal muscle reoxygenation after high-intensity exercise in mitochondrial myopathy.

Authors:  Daniela M Bravo; Ana Cristina Gimenes; Rúbia B Nascimento; Eloara V M Ferreira; Ana Cristina B Siqueira; Ethiane D S Meda; J Alberto Neder; Luiz Eduardo Nery
Journal:  Eur J Appl Physiol       Date:  2011-09-04       Impact factor: 3.078

Review 3.  The in-depth evaluation of suspected mitochondrial disease.

Authors:  Richard H Haas; Sumit Parikh; Marni J Falk; Russell P Saneto; Nicole I Wolf; Niklas Darin; Lee-Jun Wong; Bruce H Cohen; Robert K Naviaux
Journal:  Mol Genet Metab       Date:  2008-02-01       Impact factor: 4.797

4.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

Review 5.  Diagnosis and treatment of mitochondrial myopathies.

Authors:  Gerald Pfeffer; Patrick F Chinnery
Journal:  Ann Med       Date:  2011-08-25       Impact factor: 4.709

6.  Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study.

Authors:  Fabrice Rannou; Arnaud Uguen; Virginie Scotet; Cédric Le Maréchal; Odile Rigal; Pascale Marcorelles; Eric Gobin; Jean-Luc Carré; Fabien Zagnoli; Marie-Agnès Giroux-Metges
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  Exercise efficiency impairment in metabolic myopathies.

Authors:  Jean-Baptiste Noury; Fabien Zagnoli; François Petit; Pascale Marcorelles; Fabrice Rannou
Journal:  Sci Rep       Date:  2020-05-29       Impact factor: 4.379

8.  International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.

Authors:  Michelangelo Mancuso; Robert McFarland; Thomas Klopstock; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2017-09-08       Impact factor: 4.296

Review 9.  Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases.

Authors:  M Mancuso; C Angelini; E Bertini; V Carelli; G P Comi; C Minetti; M Moggio; T Mongini; S Servidei; P Tonin; A Toscano; G Uziel; M Zeviani; G Siciliano
Journal:  Neuromuscul Disord       Date:  2012-12       Impact factor: 4.296

10.  Effects of exercise continued until anaerobic threshold on balance performance in male basketball players.

Authors:  Nurtekin Erkmen; Sibel Suveren; Ahmet Salim Göktepe
Journal:  J Hum Kinet       Date:  2012-07-04       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.